These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30238771)

  • 1. Indomethacin increases severity of Clostridium difficile infection in mouse model.
    Muñoz-Miralles J; Trindade BC; Castro-Córdova P; Bergin IL; Kirk LA; Gil F; Aronoff DM; Paredes-Sabja D
    Future Microbiol; 2018 Sep; 13(11):1271-1281. PubMed ID: 30238771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate
    Maseda D; Zackular JP; Trindade B; Kirk L; Roxas JL; Rogers LM; Washington MK; Du L; Koyama T; Viswanathan VK; Vedantam G; Schloss PD; Crofford LJ; Skaar EP; Aronoff DM
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622186
    [No Abstract]   [Full Text] [Related]  

  • 3. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-27/IL-27 Receptor Signaling Provides Protection in Clostridium difficile-Induced Colitis.
    Wang L; Cao J; Li C; Zhang L
    J Infect Dis; 2018 Jan; 217(2):198-207. PubMed ID: 29140433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
    Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
    Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse relapse model of Clostridium difficile infection.
    Sun X; Wang H; Zhang Y; Chen K; Davis B; Feng H
    Infect Immun; 2011 Jul; 79(7):2856-64. PubMed ID: 21576341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection.
    Cribas ES; Denny JE; Maslanka JR; Abt MC
    Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33649048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Chicken IgY Specific to
    Pizarro-Guajardo M; Díaz-González F; Álvarez-Lobos M; Paredes-Sabja D
    Front Cell Infect Microbiol; 2017; 7():365. PubMed ID: 28856119
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial Activity of Tannic Acid
    Wang W; Cao J; Yang J; Niu X; Liu X; Zhai Y; Qiang C; Niu Y; Li Z; Dong N; Wen B; Ouyang Z; Zhang Y; Li J; Zhao M; Zhao J
    Microbiol Spectr; 2023 Feb; 11(1):e0261822. PubMed ID: 36537806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain killers: the interplay between nonsteroidal anti-inflammatory drugs and Clostridioides difficile infection.
    Soto Ocaña J; Bayard NU; Zackular JP
    Curr Opin Microbiol; 2022 Feb; 65():167-174. PubMed ID: 34894543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
    Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
    Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile-induced colitis in mice is independent of leukotrienes.
    Trindade BC; Theriot CM; Leslie JL; Carlson PE; Bergin IL; Peters-Golden M; Young VB; Aronoff DM
    Anaerobe; 2014 Dec; 30():90-8. PubMed ID: 25230329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients.
    Abu-Sbeih H; Choi K; Tran CN; Wang X; Lum P; Shuttlesworth G; Stroehlein JR; Okhuysen PC; Wang Y
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):128-134. PubMed ID: 30339561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During
    Costa DVS; Moura-Neto V; Bolick DT; Guerrant RL; Fawad JA; Shin JH; Medeiros PHQS; Ledwaba SE; Kolling GL; Martins CS; Venkataraman V; Warren CA; Brito GAC
    Front Cell Infect Microbiol; 2021; 11():739874. PubMed ID: 34568098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.
    Zhou F; Hamza T; Fleur AS; Zhang Y; Yu H; Chen K; Heath JE; Chen Y; Huang H; Feng H
    Inflamm Bowel Dis; 2018 Feb; 24(3):573-582. PubMed ID: 29462386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment.
    Li Y; Figler RA; Kolling G; Bracken TC; Rieger J; Stevenson RW; Linden J; Guerrant RL; Warren CA
    BMC Infect Dis; 2012 Dec; 12():342. PubMed ID: 23217055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
    Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
    Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral teicoplanin administration suppresses recurrence of Clostridioides difficile infection: Proof of concept.
    Tanaka Y; Tashiro S; Ikegami S; Enoki Y; Taguchi K; Matsumoto K
    Anaerobe; 2023 Dec; 84():102789. PubMed ID: 37879532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.